Filter
371
Filtered Results: 371
Text search:
Murphy,
Ben
Featured
Recommendations
37
New Publications
65
Language
Document type
No document type
206
Guidelines
65
Studies & Reports
63
Manuals
19
Strategic & Response Plan
9
Training Material
4
Fact sheets
4
Situation Updates
1
Countries / Regions
India
27
Global
14
Kenya
9
Russia
6
Liberia
5
South Africa
5
Bangladesh
5
Africa
5
Congo, Democratic Republic of
4
Uganda
4
Germany
4
Rwanda
4
Colombia
4
Myanmar / Burma
4
Latin America and the Carribbean
4
Western and Central Europe
4
Venezuela
4
Sierra Leone
3
Nigeria
3
Ghana
3
Philippines
3
Tanzania
3
Mozambique
3
Brazil
3
Eastern Europe
3
Senegal
2
Guinea-Bissau
2
Nepal
2
South Sudan
2
Zambia
2
Indonesia
2
Ukraine
2
Angola
2
Guinea
1
USA
1
Ethiopia
1
Zimbabwe
1
Pakistan
1
Syria
1
Thailand
1
China
1
Malawi
1
Benin
1
Argentina
1
Peru
1
Austria
1
Switzerland
1
Bolivia
1
Sri Lanka
1
Chile
1
Yemen
1
West and Central Africa
1
Middle East and North Africa
1
South–East Asia Region
1
Western Pacific Region
1
Paraguay
1
Asia
1
Laos
1
Tajikistan
1
Mauritius
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
97
Public Health
31
Women & Child Health
27
Clinical Guidelines
24
Key Resources
8
Capacity Building
4
Toolboxes
Mental Health
73
COVID-19
37
HIV
35
Disability
24
NCDs
21
Planetary Health
20
Caregiver
17
Ebola
14
TB
9
Global Health Education
8
AMR
6
Conflict
5
Rapid Response
5
Social Ethics
5
Polio
3
NTDs
3
Natural Hazards
2
Specific Hazards
2
Pharmacy
2
Refugee
1
Health Financing Toolbox
1
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform...
Orientations provisoires, 2 février 2021
e document est une mise à jour des orientations provisoires de l’Organisation mondiale de la Santé (OMS) intitulées Coronavirus disease (COVID-19) outbreak: rights, roles and responsibilities of health workers, including key considerations...
COVID-19: occupational health and safety for health workers: interim guidance, Interim guidance 2 February 2021
Health workers are at the front line of the COVID-19 outbreak response and as such are exposed to different hazards that put them at risk. Occupational hazards include exposure to SARS-C...
Esta primeira versão de Medicamentos para prevenção da COVID-19: Orientação dinâmica da OMS aborda o uso de hidroxicloroquina para prevenção da COVID-19. Segue-se a publicação de uma análise sistemática e NMA que reuniu dados de seis estudos com 6.059 participantes que não tinham COVID-...
A study conducted by the World Health Organisation Regional Office for Africa. The COVID-19 pandemic has had a significant impact on older persons both globally and in the African region. Although overall the region’s population is younger relative to many other world regions, the WHO AFRO region ...
Resumo: o que é esta orientação dinâmica?
Pergunta clínica: qual é o papel dos medicamentos na prevenção da COVID-19?
Público-alvo: o público-alvo são os médicos e os tomadores de decisão na área da saúde.
Prática atual: o uso atual de medicamentos para prevenção da COVID-19 é ...
This article provides an overview of the current and projected climate change risks and impacts to mental health and provides recommendations for priority actions to address the mental health consequences of climate change.
The WHO Living guideline: Drugs to prevent COVID-19 contains the Organization’s most up-to-date recommendations for the use of drugs to prevent COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform.
Guidelines ...
The cardiovascular disease continuum begins with risk factors such as diabetes mellitus (DM), progresses to vasculopathy and myocardial dysfunction, and finally ends with cardiovascular death. Diabetes is associated with a 2- to 4-fold increased risk for heart failure (HF). Moreover, HF patients wit...
WHO has published the first-ever guidance on the clinical management of diphtheria. The only previously available guidance was an operational protocol. The new guidance followed the rigorous process for developing guidance at WHO.
It addresses the use of Diphtheria Antitoxin (DAT) in the treatmen...
The incidence and mortality of cardiovascular diseases (CVDs) in low and middle income countries (LMICs) have been increasing, while access to CVDs medicines is suboptimal. We assessed selection of essential medicines for the prevention and treatment of CVDs on national essential medicines lists (NE...
